TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be? September 26, 1986
TCL Archive Group Chairmen Approve Policy On Industry Support; NCI Turns Down Request To “Launder” Contributions December 16, 1983
